H. Ward Wolff

2012

In 2012, H. Ward Wolff earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at Sangamo Biosciences, a 67% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$157,950
Option Awards$340,740
Salary$390,000
Stock Awards$243,450
Total$1,132,140

Wolff received $390K in salary, accounting for 34% of the total pay in 2012.

Wolff also received $158K in non-equity incentive plan, $340.7K in option awards and $243.5K in stock awards.

Rankings

In 2012, H. Ward Wolff's compensation ranked 5,642nd out of 11,487 executives tracked by ExecPay. In other words, Wolff earned more than 50.9% of executives.

ClassificationRankingPercentile
All
5,642
out of 11,487
51st
Division
Manufacturing
2,000
out of 4,253
53rd
Major group
Chemicals And Allied Products
483
out of 1,198
60th
Industry group
Drugs
324
out of 920
65th
Industry
Biological Products, Except Diagnostic Substances
56
out of 160
65th
Source: SEC filing on March 11, 2014.

Wolff's colleagues

We found four more compensation records of executives who worked with H. Ward Wolff at Sangamo Biosciences in 2012.

2012

Edward Lanphier

Sangamo Biosciences

Chief Executive Officer

2012

Geoffrey Nichol

Sangamo Biosciences

Executive Vice President, Research and Development

2012

Dale Ando

Sangamo Biosciences

Chief Medical Officer

2012

Philip Gregory

Sangamo Biosciences

Chief Scientific Officer

You may also like